Single-label DNA fiber analysis of stressed replication fork degradation. MDA-MB-436 BRCA1-/- cells were transiently transfected with control, EEPD1 and/or RAD52 siRNA for 48 h and labeled with IdU for 45 min before proceeding to either 0 h or 10 h incubation with 5 mM HU. DNA degradation at stalled nascent replication forks was measured by fiber analysis. a Schematic diagram depicts steps for the DNA fiber assay and representative images of DNA fibers from each condition. IdU stained red (stalled forks). Quantitative analysis of IdU track length frequency at unstressed (no HU) (b), or HU-treated DNA fibers (c) from each condition. d Bar chart from the HU-treated IdU track length frequencies analysis. c and d are the same data. Co-depletion...
Figure S4. IKKε and p52 or MEK supports viability in LA conditions in at least two TNBC lines. Growt...
Figure S1. Test of the Poisson distribution of nonsense mutations in URA3. Figure S2. The effect of ...
Frequency of indels and non-indels in each MAF dataset. Distribution of mutation frequency across MA...
EEPD1 depletion in SUM149PT BRCA1 mutant breast cancer cells rescues synthetic lethality from RAD52 ...
EEPD1 depletion in BRCA1-depleted MCF7 breast cancer cells rescues synthetic lethality from RAD52 de...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
Figure S3 Growth curve of MDA-MB-468 cells depleted (si-ID4) or not (si-SCR) of ID4 expression by si...
APOBEC3B expression and activity in breast cancer cell lines. a Boxplot showing number of SCNA break...
Figure S3. IKKε inhibits activity of p52. qRT-PCR and ChIP-PCR results for MDA MB 231 cell line and ...
Replication stress correlates with APOBEC3 activation. a MCF7 cells were treated with the indicated ...
<p>(A) Replication recovery assayed as percentage of cells with ≥3 BrdU foci 2 h after release from ...
Western blot analysis of ORF2 proteins containing mutations in putative phosphorylation sites. Top p...
Clinical trial BR9601 information. (a) Schematic representation. (b) Patient information. Figure S2....
Experimental approach for the acute and chronic toxicity assays: A) Acute toxicity assay: Cells are ...
Figure S4. IKKε and p52 or MEK supports viability in LA conditions in at least two TNBC lines. Growt...
Figure S1. Test of the Poisson distribution of nonsense mutations in URA3. Figure S2. The effect of ...
Frequency of indels and non-indels in each MAF dataset. Distribution of mutation frequency across MA...
EEPD1 depletion in SUM149PT BRCA1 mutant breast cancer cells rescues synthetic lethality from RAD52 ...
EEPD1 depletion in BRCA1-depleted MCF7 breast cancer cells rescues synthetic lethality from RAD52 de...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
Figure S3 Growth curve of MDA-MB-468 cells depleted (si-ID4) or not (si-SCR) of ID4 expression by si...
APOBEC3B expression and activity in breast cancer cell lines. a Boxplot showing number of SCNA break...
Figure S3. IKKε inhibits activity of p52. qRT-PCR and ChIP-PCR results for MDA MB 231 cell line and ...
Replication stress correlates with APOBEC3 activation. a MCF7 cells were treated with the indicated ...
<p>(A) Replication recovery assayed as percentage of cells with ≥3 BrdU foci 2 h after release from ...
Western blot analysis of ORF2 proteins containing mutations in putative phosphorylation sites. Top p...
Clinical trial BR9601 information. (a) Schematic representation. (b) Patient information. Figure S2....
Experimental approach for the acute and chronic toxicity assays: A) Acute toxicity assay: Cells are ...
Figure S4. IKKε and p52 or MEK supports viability in LA conditions in at least two TNBC lines. Growt...
Figure S1. Test of the Poisson distribution of nonsense mutations in URA3. Figure S2. The effect of ...
Frequency of indels and non-indels in each MAF dataset. Distribution of mutation frequency across MA...